Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide.
- This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide.
- In many cases these laboratories face significant sample backlog due to volume and may have difficulties in identifying new designer drugs.
- These tools will not only identify known illicit drugs but will also identify unknown drugs that are derivatives of known illicit substances also referred to as designer drugs or new psychoactive substances (NPS).
- The company is developing this application in the context of its quantitative NMR platform technology, which has other applications as well, beyond illicit drug detection.